Silence Therapeutics (SLN) Non-Current Deferred Revenue (2019 - 2026)
Silence Therapeutics (SLN) reported Non-Current Deffered Revenue of $55.22 million for the quarter ended Jun 30, 2026, down 1.9% from $56.31 million a year earlier and unchanged from the prior quarter.
Powered by 
Analysis
Silence Therapeutics (SLN) Non-Current Deferred Revenue (2019 - 2026) Analysis & Trends
As of Dec 31, 2025, Silence Therapeutics posted Non-Current Deffered Revenue of $55.45 million, up 7.1% from the prior year.
- By year, Non-Current Deffered Revenue came in at $51.79 million in the year ended Dec 31, 2024 (-30.9%) and $75 million in the year ended Dec 31, 2023.
- Five-year quarterly Non-Current Deffered Revenue spans a low of $51.79 million in the quarter ended Dec 31, 2024 and a high of $75 million in the quarter ended Dec 31, 2023.
- Year over year, Non-Current Deffered Revenue gained in two of the last four quarters, with an average decline of 5.5%.
- Per Business Quant data, the three quarters before the quarter ended Jun 30, 2026 came in at $55.22 million (quarter ended Mar 31, 2026), $55.45 million (quarter ended Dec 31, 2025) and $55.25 million (quarter ended Sep 30, 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn |
| 10 | Silence Therapeutics | 935.01 Mn | 862.91 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 55.22 Mn |
| Mar 31, 2026 | 55.22 Mn |
| Dec 31, 2025 | 55.45 Mn |
| Sep 30, 2025 | 55.25 Mn |
| Jun 30, 2025 | 56.31 Mn |
| Mar 31, 2025 | 53.29 Mn |
| Dec 31, 2024 | 51.79 Mn |
| Sep 30, 2024 | -77.56 Mn |
| Jun 30, 2024 | -73.58 Mn |
| Mar 31, 2024 | -70.97 Mn |
| Dec 31, 2023 | 75.00 Mn |
| Sep 30, 2023 | -73.00 Mn |
| Jun 30, 2023 | -76.61 Mn |
| Mar 31, 2023 | -74.03 Mn |
| Dec 31, 2022 | -76.54 Mn |
| Sep 30, 2022 | -71.45 Mn |
| Jun 30, 2022 | -83.21 Mn |
| Mar 31, 2022 | -88.12 Mn |
| Dec 31, 2021 | -97.86 Mn |
| Sep 30, 2021 | -77.87 Mn |
API Access
Silence Therapeutics Non-Current Deferred Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-current-deffered-revenue&ticker=SLN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-current-deffered-revenue", "ticker": "SLN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-current-deffered-revenue&ticker=SLN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();